1642297-01-5
1642297-01-5
Chemical Structure
GDC-0927
Synonym(s): SRN-927
- CAS No.: 1642297-01-5
- Formula:C28H28FNO4
- Molecular Weight:461.52
IUPAC Name: (S)-2-(4-(2-(3-(fluoromethyl)azetidin-1-yl)ethoxy)phenyl)-3-(3-hydroxyphenyl)-4-methyl-2H-chromen-6-ol
InChIKey: KJAAPZIFCQQQKX-NDEPHWFRSA-N
SMILES: OC1=CC=C2C(C(C)=C(C3=CC=CC(O)=C3)[C@H](C4=CC=C(OCCN5CC(CF)C5)C=C4)O2)=C1
Biological Activity: GDC-0927 (SRN-927) is a potent, non-steroidal, orally bioavailable, selective estrogen receptor antagonist[1].
| Cat. No. | Nom du produit | Pureté | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
GDC-0927 | 99.98% | GDC-0927 (SRN-927) is a potent, non-steroidal, orally bioavailable, selective estrogen receptor antagonist. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
GDC-0927 (Standard) | ≥98% | GDC-0927 (Standard) is the analytical standard of GDC-0927 (HY-111484). This product is intended for research and analytical applications. GDC-0927 (SRN-927) is a potent, non-steroidal, orally bioavailable, selective estrogen receptor antagonist. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
